Hantz Financial Services’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$0 Hold
50
﹤0.01% 2508
2025
Q4
$0 Hold
50
﹤0.01% 2456
2025
Q3
$0 Hold
50
﹤0.01% 2372
2025
Q2
$0 Hold
50
﹤0.01% 2226
2025
Q1
$0 Hold
50
﹤0.01% 1808
2024
Q4
$0 Hold
50
﹤0.01% 1135
2024
Q3
$0 Hold
50
﹤0.01% 1113
2024
Q2
$0 Hold
50
﹤0.01% 1132
2024
Q1
$0 Hold
50
﹤0.01% 1226
2023
Q4
$0 Hold
50
﹤0.01% 1151
2023
Q3
$0 Hold
50
﹤0.01% 1137
2023
Q2
$0 Hold
50
﹤0.01% 1112
2023
Q1
$0 Hold
50
﹤0.01% 1136
2022
Q4
$0 Hold
50
﹤0.01% 1103
2022
Q3
$0 Hold
50
﹤0.01% 1092
2022
Q2
$0 Hold
50
﹤0.01% 1066
2022
Q1
$1K Buy
+50
New +$1.15K ﹤0.01% 988

Other funds holding GDRX

Hantz Financial Services's GDRX Position: Q1 2026 in Review

Hantz Financial Services held its GoodRx Holdings (GDRX) position steady in Q1 2026 at 50 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2508.

Hantz Financial Services first reported a position in GDRX in Q1 2022 and has held it in 17 quarters since. The position peaked at $1K in Q1 2022. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Hantz Financial Services held 50 shares of GoodRx Holdings worth $0 as of Q1 2026.
  • Hantz Financial Services left its GoodRx Holdings share count unchanged in Q1 2026.
  • GoodRx Holdings made up ﹤0.01% of Hantz Financial Services's portfolio in Q1 2026, its #2508 holding.
  • Hantz Financial Services first reported a position in GoodRx Holdings in Q1 2022 and has held it in 17 quarters since.
  • Hantz Financial Services's GoodRx Holdings position peaked at $1K in Q1 2022.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Hantz Financial Services's 13F filing for Q1 2026, filed 1 May 2026.